4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-23-031781
Options or other derivatives
- Director acquired 24,058 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bronstein Ben Director | 2023-06-30 | Grant or award · Stock Option (Right to Buy) | +21,222 | 21,222 | D | ||
| Bronstein Ben Director | 2023-06-30 | Grant or award · Stock Option (Right to Buy) | +1,372 | 1,372 | D | ||
| Bronstein Ben Director | 2023-06-30 | Grant or award · Stock Option (Right to Buy) | +1,464 | 1,464 | D | ||
Loading xslF345X04/ownership.xml…